Drew Moghanaki

3.2k total citations · 2 hit papers
118 papers, 2.2k citations indexed

About

Drew Moghanaki is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Drew Moghanaki has authored 118 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 48 papers in Radiation and 30 papers in Oncology. Recurrent topics in Drew Moghanaki's work include Advanced Radiotherapy Techniques (48 papers), Lung Cancer Diagnosis and Treatment (40 papers) and Prostate Cancer Treatment and Research (30 papers). Drew Moghanaki is often cited by papers focused on Advanced Radiotherapy Techniques (48 papers), Lung Cancer Diagnosis and Treatment (40 papers) and Prostate Cancer Treatment and Research (30 papers). Drew Moghanaki collaborates with scholars based in United States, Canada and Australia. Drew Moghanaki's co-authors include Robert D. Cardiff, Mitchell S. Anscher, Simon S. Lo, Tomer Z. Karas, Carol L. MacLeod, Lesley G. Ellies, Lawrence J.T. Young, Jeannie E. Maglione, Bridget F. Koontz and Sorena Nadaf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Drew Moghanaki

112 papers receiving 2.1k citations

Hit Papers

Stereotactic body radiation therapy for early-stage non-s... 2016 2026 2019 2022 2017 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drew Moghanaki United States 21 1.3k 687 506 409 283 118 2.2k
Abigail T. Berman United States 28 1.2k 0.9× 720 1.0× 503 1.0× 473 1.2× 130 0.5× 102 1.9k
S. Supiot France 31 1.7k 1.4× 632 0.9× 840 1.7× 880 2.2× 535 1.9× 231 3.1k
Erqi L. Pollom United States 27 1.0k 0.8× 924 1.3× 409 0.8× 566 1.4× 152 0.5× 195 2.8k
Gina Lockwood Canada 25 1.3k 1.0× 629 0.9× 389 0.8× 795 1.9× 756 2.7× 93 3.4k
D.A. Loblaw Canada 29 2.5k 2.0× 587 0.9× 877 1.7× 487 1.2× 307 1.1× 88 3.4k
Rafi Kabarriti United States 19 422 0.3× 951 1.4× 180 0.4× 382 0.9× 328 1.2× 115 2.0k
Kirtesh R. Patel United States 25 1.4k 1.1× 957 1.4× 195 0.4× 255 0.6× 282 1.0× 83 2.1k
Alfredo Zurlo Italy 14 1.6k 1.3× 513 0.7× 427 0.8× 222 0.5× 175 0.6× 51 2.2k
Amol Narang United States 21 705 0.6× 1.2k 1.8× 205 0.4× 341 0.8× 136 0.5× 140 2.1k
A. L. J. Uitterhoeve Netherlands 10 1.6k 1.3× 895 1.3× 597 1.2× 664 1.6× 90 0.3× 13 2.4k

Countries citing papers authored by Drew Moghanaki

Since Specialization
Citations

This map shows the geographic impact of Drew Moghanaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Moghanaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Moghanaki more than expected).

Fields of papers citing papers by Drew Moghanaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew Moghanaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Moghanaki. The network helps show where Drew Moghanaki may publish in the future.

Co-authorship network of co-authors of Drew Moghanaki

This figure shows the co-authorship network connecting the top 25 collaborators of Drew Moghanaki. A scholar is included among the top collaborators of Drew Moghanaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew Moghanaki. Drew Moghanaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Minji, D O’Connell, Ann C. Raldow, et al.. (2025). A Retrospective Analysis of the First Clinical 5DCT Workflow. Cancers. 17(3). 531–531. 1 indexed citations
2.
Heiden, Brendan T., Daniel B. Eaton, Jatinder Palta, et al.. (2025). Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer. JNCI Cancer Spectrum. 9(6).
3.
Moghanaki, Drew, et al.. (2025). Opportunities for Predicting Lung Cancer Screening Nonadherence: A Systematic Review and Meta-Analysis. Journal of the American College of Radiology. 22(12). 1483–1499.
4.
Moghanaki, Drew, Sue S. Yom, & Neha Vapiwala. (2025). Missing the Target: Radiation, “Toxicity,” and Public Fear. International Journal of Radiation Oncology*Biology*Physics. 124(1). 39–40.
5.
Yanagawa, Jane, Alan Lee, Jie Deng, et al.. (2024). Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer. JTO Clinical and Research Reports. 5(7). 100690–100690. 1 indexed citations
6.
Johnston, Fabian M., Ana P. Kiess, Kedar Kirtane, et al.. (2024). The History and Future of Multidisciplinary Cancer Care. Seminars in Radiation Oncology. 34(4). 441–451. 1 indexed citations
7.
Wang, Zitian, Fang‐I Chu, Victoria Yu, et al.. (2023). Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning. Cancers. 15(15). 3916–3916. 4 indexed citations
8.
Sebastian, Nikhil, William Stokes, Madhusmita Behera, et al.. (2023). The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clinical Lung Cancer. 24(3). 287–294. 13 indexed citations
9.
Edwards, Donna M., K. Nathan Sankar, Matthew J. Schipper, et al.. (2023). Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(4). 963–970. 8 indexed citations
10.
Valle, Luca, Fang‐I Chu, Marc A. Smith, et al.. (2022). Characterizing Twitter Influencers in Radiation Oncology. Advances in Radiation Oncology. 7(6). 100919–100919. 4 indexed citations
11.
Bryant, Alex K., K. Nathan Sankar, Lili Zhao, et al.. (2022). De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer. European Journal of Cancer. 171. 55–63. 17 indexed citations
12.
Yoon, Stephanie, Robert D. Suh, Fereidoun Abtin, et al.. (2021). Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation. Radiation Oncology. 16(1). 99–99. 10 indexed citations
13.
Malhotra, Sheetal, Michael P. Hagan, Katherine Faricy‐Anderson, et al.. (2020). Palliative Radiotherapy within the Veterans Health Administration: Barriers to Referral and Timeliness of Treatment. International Journal of Radiation Oncology*Biology*Physics. 108(3). e164–e164. 2 indexed citations
14.
Moghanaki, Drew. (2020). Strategic Initiatives for Veterans with Lung Cancer. Federal Practitioner. 37(Suppl 4). S76–S80. 6 indexed citations
15.
Lewis, Jennifer A., Lucy B. Spalluto, Claudia I. Henschke, et al.. (2020). Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration. Clinical Imaging. 73. 151–161. 12 indexed citations
16.
Moghanaki, Drew, Ben J. Slotman, Anand Swaminath, Benjamin E. Nelms, & Brian Wang. (2019). Assessing the Variability and Quality of Lung Stereotactic Radiation Therapy Treatment Plans Using a Web-Based Crowdsourcing Platform. Practical Radiation Oncology. 10(3). e118–e127. 5 indexed citations
17.
Moghanaki, Drew, Lauren E. Howard, Amanda M. De Hoedt, et al.. (2019). Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer. Prostate Cancer and Prostatic Diseases. 22(4). 633–635. 12 indexed citations
18.
Митин, Тимур, Drew Moghanaki, Charles R. Thomas, et al.. (2018). Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey. Advances in Radiation Oncology. 3(2). 125–129. 9 indexed citations
19.
Williams, Christina D., Joseph K. Salama, Drew Moghanaki, Tomer Z. Karas, & Michael J. Kelley. (2016). Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer. Journal of Thoracic Oncology. 11(10). 1672–1681. 60 indexed citations
20.
Dikov, Mikhail M., Joyce E. Ohm, Neelanjan Ray, et al.. (2005). Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation. The Journal of Immunology. 174(1). 215–222. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026